{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:52:12Z","timestamp":1785883932754,"version":"3.56.0"},"reference-count":116,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T00:00:00Z","timestamp":1288828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>If vitiligo involves most of the body, it might be easier to depigment the normal remaining skin rather than to attempt repigmentation. We reviewed the literature to date regarding available therapies for depigmenting the normal skin in vitiligo universalis. Our review revealed that the threshold regarding what percentage of body surface area qualifies as depigmentation is variable among practitioners. Monobenzyl ether of hydroquinone (MBEH) is the most widely used depigmenting agent and has few side\u2010effects. Tretinoin in combination with MBEH is able to speed depigmentation of the skin. Monomethylether of hydroquinone has also been used successfully for depigmentation. Eighty\u2010eight per cent phenol is also effective in depigmenting the skin but its application on large areas is toxic for liver and kidney. Different types of lasers are also available to destruct the melanocytes selectively, but this technique can be painful and expensive. Cryotherapy is a cheap depigmenting therapy but, because of scarring risk, it should only be used by experienced dermatologists. No trials have compared the efficacy of the above\u2010mentioned well\u2010established depigmentation agents\/techniques. Certain drugs such as imatinib, imiquimod and diphencyprone, which are used to treat other diseases, caused depigmentation as a side\u2010effect. Some depigmentation agents used for branding cattle can also serve as topical depigmentation agents. In conclusion, comparative clinical trials are needed to compare the efficacy of various depigmentation agents\/techniques. In particular, topical imatinib, imiquimod and diphencyprone may be considered as potential depigmenting agents, which require further investigation. This review revealed that MBEH is safe and effective depigmenting agent.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2010.03876.x","type":"journal-article","created":{"date-parts":[[2010,11,6]],"date-time":"2010-11-06T09:16:25Z","timestamp":1289034985000},"page":"749-757","source":"Crossref","is-referenced-by-count":79,"title":["Depigmentation therapies for normal skin in vitiligo universalis"],"prefix":"10.1111","volume":"25","author":[{"given":"K.M.","family":"AlGhamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,4]]},"reference":[{"key":"e_1_2_13_2_2","first-page":"251","volume-title":"Dermatology in General Medicine","author":"Wick MM","year":"1987"},{"key":"e_1_2_13_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.1989.tb00166.x"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.32.1091"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00595220"},{"key":"e_1_2_13_6_2","article-title":"Interventions for vitiligo [systematic review]","author":"Whitton ME","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2003.01207.x"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.32708"},{"key":"e_1_2_13_9_2","first-page":"513","volume-title":"The Pigmentary System: Physiology and Pathophysiology","author":"Nordlund JJ","year":"1998"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-8343(79)90081-1"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01369.x"},{"key":"e_1_2_13_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70028-G"},{"key":"e_1_2_13_13_2","first-page":"493","article-title":"Response to cosmetic disfigurement: patients with vitiligo","volume":"39","author":"Porter J","year":"1987","journal-title":"Cutis"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103813"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03310.x"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08881.x"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2001.01101.x"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00038.x"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1996.tb01014.x"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1986.tb01448.x"},{"key":"e_1_2_13_21_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00029.x"},{"key":"e_1_2_13_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1529-8019.2001.014001029.x"},{"key":"e_1_2_13_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2006.00441.x"},{"key":"e_1_2_13_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1953.tb13174.x"},{"key":"e_1_2_13_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1953.03690070011004"},{"key":"e_1_2_13_26_2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.1965.03090220021006","article-title":"Topical use of hydroquinone as a depigmenting agent","volume":"194","author":"Arndt KA","year":"1965","journal-title":"J Am Med Assoc"},{"key":"e_1_2_13_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1977.tb14275.x"},{"key":"e_1_2_13_28_2","first-page":"945","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Freedberg IM","year":"1999"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1941.32"},{"key":"e_1_2_13_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1952.16"},{"key":"e_1_2_13_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.214"},{"key":"e_1_2_13_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711010211"},{"key":"e_1_2_13_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1710970202"},{"key":"e_1_2_13_34_2","first-page":"641","article-title":"Acquired leukomelanoderma caused by topical depigmenting agents","volume":"109","author":"Grojean MF","year":"1982","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_13_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1964.01600010069015"},{"key":"e_1_2_13_36_2","first-page":"153","article-title":"Depigmentation par agents chimiques","volume":"78","author":"Frenk E","year":"1971","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"e_1_2_13_37_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243040-00005"},{"key":"e_1_2_13_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30271-7"},{"key":"e_1_2_13_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90691-X"},{"key":"e_1_2_13_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1960.03730020081012"},{"key":"e_1_2_13_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1983.01040010066010"},{"key":"e_1_2_13_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1975.01630130042004"},{"key":"e_1_2_13_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1997.tb00238.x"},{"key":"e_1_2_13_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12363627"},{"key":"e_1_2_13_45_2","doi-asserted-by":"publisher","DOI":"10.1159\/000069938"},{"key":"e_1_2_13_46_2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1242\/jcs.107.4.1095","article-title":"Retinoic acid as modulator of UVB\u2010induced melanogenic enzymes expression","volume":"107","author":"Romero C","year":"1994","journal-title":"J Cell Sci"},{"key":"e_1_2_13_47_2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archderm.1985.01660090055013","article-title":"Dermatitis produced by applications of monobenzone in patients with active vitiligo","volume":"121","author":"Nordlund JJ","year":"1985","journal-title":"Arch Dermatol"},{"key":"e_1_2_13_48_2","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.57602"},{"key":"e_1_2_13_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03351.x"},{"key":"e_1_2_13_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2005.01.001"},{"key":"e_1_2_13_51_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1529-8019.2001.014001029.x"},{"key":"e_1_2_13_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.02.020"},{"key":"e_1_2_13_53_2","volume-title":"The Extra Pharmacopoeia. Martindale","author":"Reynolds JEF","year":"1989"},{"key":"e_1_2_13_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90219-6"},{"key":"e_1_2_13_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1985.tb00544.x"},{"key":"e_1_2_13_56_2","first-page":"137","volume-title":"Chemical Peeling and Resurfacing","author":"Brody HJ","year":"1997"},{"key":"e_1_2_13_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.1999.98246.x"},{"key":"e_1_2_13_58_2","first-page":"9","article-title":"Treatment of photoaging: facial chemical peeling (phenol and trichloroaceticacid) and dermabrasion","volume":"20","author":"Stuzin JM","year":"1993","journal-title":"Clin Plast Surg"},{"key":"e_1_2_13_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.1954"},{"key":"e_1_2_13_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1998.tb05863.x"},{"key":"e_1_2_13_61_2","first-page":"171","volume-title":"Chemical Peels","author":"Coleman KM","year":"2006"},{"key":"e_1_2_13_62_2","volume-title":"Toxicological Profile for Phenol","author":"Agency for Toxic Substances and Disease Registry (ATSDR)","year":"1998"},{"key":"e_1_2_13_63_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962005000400013"},{"key":"e_1_2_13_64_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00144.x"},{"key":"e_1_2_13_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-199209000-00007"},{"key":"e_1_2_13_66_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.1999.08122.x"},{"key":"e_1_2_13_67_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6836297"},{"key":"e_1_2_13_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90827-0"},{"key":"e_1_2_13_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90013-6"},{"key":"e_1_2_13_70_2","doi-asserted-by":"publisher","DOI":"10.1080\/14628839950516698"},{"key":"e_1_2_13_71_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2001.01094.x"},{"key":"e_1_2_13_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30313.x"},{"key":"e_1_2_13_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(94)00031-V"},{"key":"e_1_2_13_74_2","doi-asserted-by":"publisher","DOI":"10.1053\/sder.2002\/36765"},{"key":"e_1_2_13_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1994.tb00152.x"},{"key":"e_1_2_13_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70261-6"},{"key":"e_1_2_13_77_2","first-page":"2365","article-title":"Cryosurgery for common skin conditions","volume":"69","author":"Andrews MD","year":"2004","journal-title":"Am Fam Physician"},{"key":"e_1_2_13_78_2","first-page":"648","article-title":"American Academy of Dermatology Committee on guidelines of care","volume":"31","author":"Guidelines of care for cryosurgery","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_13_79_2","first-page":"788","article-title":"Cryotherapy in the treatment of pyogenic granuloma","volume":"20","author":"Mirshams M","year":"2006","journal-title":"JEADV"},{"key":"e_1_2_13_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70057-5"},{"key":"e_1_2_13_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.12.023"},{"key":"e_1_2_13_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20267"},{"key":"e_1_2_13_83_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11812"},{"key":"e_1_2_13_84_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D3472203P2","article-title":"Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST","volume":"14","author":"Alexandrescu DT","year":"2008","journal-title":"Dermatol Online J"},{"key":"e_1_2_13_85_2","unstructured":"US Food and Drug Administration.Aldara (imiquimod) 5% cream (online 14 July 2004). [WWW document]. URLhttp:\/\/www.fda.gov\/cder\/foi\/label\/2004\/20723s016lbl.pdf(last accessed 1 December 2006)."},{"key":"e_1_2_13_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2008.12.017"},{"key":"e_1_2_13_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0192-0561(98)00068-X"},{"key":"e_1_2_13_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.10.422"},{"key":"e_1_2_13_89_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0366-077X.2003.05630.x"},{"key":"e_1_2_13_90_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.126215"},{"key":"e_1_2_13_91_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.113689"},{"key":"e_1_2_13_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0883"},{"key":"e_1_2_13_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.10.861"},{"key":"e_1_2_13_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(02)00094-3"},{"key":"e_1_2_13_95_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0749.2003.00023.x"},{"key":"e_1_2_13_96_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.126586"},{"key":"e_1_2_13_97_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-001-0134-6"},{"key":"e_1_2_13_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2004.08.007"},{"key":"e_1_2_13_99_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666130-00001"},{"key":"e_1_2_13_100_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0366-077X.2003.05634.x"},{"key":"e_1_2_13_101_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.10.1325"},{"key":"e_1_2_13_102_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2003.29399.x"},{"key":"e_1_2_13_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06094.x"},{"key":"e_1_2_13_104_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg016"},{"key":"e_1_2_13_105_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-009-1012-0"},{"key":"e_1_2_13_106_2","first-page":"947","volume-title":"Dermatology","author":"Ortonne JP","year":"2003"},{"key":"e_1_2_13_107_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb03835.x"},{"key":"e_1_2_13_108_2","doi-asserted-by":"publisher","DOI":"10.1159\/000248532"},{"key":"e_1_2_13_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb06306.x"},{"key":"e_1_2_13_110_2","first-page":"276","article-title":"Vitiligo as an adverse reaction to topical diphencyprone","volume":"38","author":"Pan JY","year":"2009","journal-title":"Ann Acad Med"},{"key":"e_1_2_13_111_2","volume-title":"Dermatotoxicology and Pharmacology","author":"Gellin GA","year":"1983"},{"key":"e_1_2_13_112_2","doi-asserted-by":"publisher","DOI":"10.2527\/1994.7261393x"},{"key":"e_1_2_13_113_2","volume-title":"Methods in Membrane Biology","author":"Bangham AD","year":"1974"},{"key":"e_1_2_13_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70342-X"},{"key":"e_1_2_13_115_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.37065"},{"key":"e_1_2_13_116_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2009.00541.x"},{"key":"e_1_2_13_117_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03412.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2010.03876.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2010.03876.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T01:20:56Z","timestamp":1697332856000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2010.03876.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,4]]},"references-count":116,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1111\/j.1468-3083.2010.03876.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03876.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,4]]}}}